Stephan Wnendt

This inventor holds 19 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Medical Implants. Top assignees: Gruenenthal Gmbh, Volcano Corporation, Abbott Laboratories Vascular Enterprises Limited. Active years: 1997-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephan Wnendt. Retrieved from https://idiyas.com/inventor/stephan-wnendt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19 (Patent Applications = 2)

% Patents Active = 68.4

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 3.6

ph-index = 7

Forward Citations = 256(Granted Patents)

Location History:

Aachen-Forst, DE (1997 - 1998)
Aachen, DE (1999 - 2023)

Company Filing History:

Abbott Laboratories Vascular Enterprises Limited

Mlm Medical Labs Gmbh

where one patent can have more than one assignee

Years Active: 1997-2023

Loading Chart...

Areas of Expertise:

Biological Material

Ultrasonic Imaging

Medical Implants

Ischemia Treatment

Stem Cells

Proteinase Inhibitors

Immunomodulating Agents

Fibrinolytic Properties

Chimeric Proteins

Morphine Derivatives

Pharmaceutical Compounds

Thrombin-Inhibiting

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11723358 - Container system for transport of biological material, uses thereof and methods of packaging (2023-08-15),

2. 8819928 - Ultrasonic imaging catheters (2014-09-02),

3. 8613906 - Treatment of ischemia using stem cells (2013-12-24),

4. 8187320 - Medical implants containing FK506 (tacrolimus) (2012-05-29),

5. 7762954 - Ultrasonic imaging catheters (2010-07-27),

6. 7678834 - Substituted 4-aminocyclohexanol compounds (2010-03-16),

7. 7183436 - Substituted 4-aminocyclohexanols (2007-02-27),

8. 7037269 - Ultrasonic imagining catheters (2006-05-02),

9. 7012099 - Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments (2006-03-14),

10. 6509368 - Use of catechol derivatives as proteinase inhibitors (2003-01-21),

11. 6500845 - Lactam derivatives as immunomodulating agents (2002-12-31),

12. 6476044 - Use of morphine derivatives as medicaments for the treatment of neuropathic problems (2002-11-05),

13. 6417197 - Acylated n-hydroxy methyl thalidomide prodrugs with immunomodulator action (2002-07-09),

14. 6133011 - Chimeric proteins having fibrinolytic and thrombin-inhibiting properties (2000-10-17),

15. 6110941 - Compounds analogous to thalidomide from the class comprising (2000-08-29),

Title: Stephan Wnendt - Innovative Inventor from Aachen

Introduction: Stephan Wnendt is a renowned inventor based in Aachen, Germany, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Stephan Wnendt holds several patents in the areas of renewable energy technologies, sustainable materials, and advanced manufacturing processes, showcasing his commitment to developing solutions for a greener future.

Career Highlights: With a career spanning over two decades, Stephan Wnendt has worked with leading research institutions and companies to bring his inventions to life. His dedication to pushing the boundaries of technology has earned him recognition in the industry.

Collaborations: Stephan Wnendt has collaborated with experts from around the world, including engineers, scientists, and designers, to combine knowledge and expertise in developing cutting-edge solutions. His collaborative approach has led to the successful implementation of several innovative projects.

Conclusion: Stephan Wnendt's passion for innovation and his relentless pursuit of excellence have established him as a key figure in the world of inventors. His contributions continue to inspire the next generation of innovators to create a better tomorrow.

Profile summary based on public USPTO records.